Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During Exercise
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study will investigate free fatty acid and VLDL-TG metabolism before and during exercise
with and without pharmacological antilipolysis by the niacin antagonist Acipimox. Main
focuses will be VLDL-TG and free fatty acid metabolism as well as expression of membrane
proteins in fat- and muscle biopsies.